Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade
- PMID: 37931708
- DOI: 10.1016/j.jaci.2023.10.021
Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade
Abstract
Background: Patients with severe asthma can present with eosinophilic type 2 (T2), neutrophilic, or mixed inflammation that drives airway remodeling and exacerbations and represents a major treatment challenge. The common β (βc) receptor signals for 3 cytokines, GM-CSF, IL-5, and IL-3, which collectively mediate T2 and neutrophilic inflammation.
Objective: To determine the pathogenesis of βc receptor-mediated inflammation and remodeling in severe asthma and to investigate βc antagonism as a therapeutic strategy for mixed granulocytic airway disease.
Methods: βc gene expression was analyzed in bronchial biopsy specimens from patients with mild-to-moderate and severe asthma. House dust mite extract and Aspergillus fumigatus extract (ASP) models were used to establish asthma-like pathology and airway remodeling in human βc transgenic mice. Lung tissue gene expression was analyzed by RNA sequencing. The mAb CSL311 targeting the shared cytokine binding site of βc was used to block βc signaling.
Results: βc gene expression was increased in patients with severe asthma. CSL311 potently reduced lung neutrophils, eosinophils, and interstitial macrophages and improved airway pathology and lung function in the acute steroid-resistant house dust mite extract model. Chronic intranasal ASP exposure induced airway inflammation and fibrosis and impaired lung function that was inhibited by CSL311. CSL311 normalized the ASP-induced fibrosis-associated extracellular matrix gene expression network and strongly reduced signatures of cellular inflammation in the lung.
Conclusions: βc cytokines drive steroid-resistant mixed myeloid cell airway inflammation and fibrosis. The anti-βc antibody CSL311 effectively inhibits mixed T2/neutrophilic inflammation and severe asthma-like pathology and reverses fibrosis gene signatures induced by exposure to commonly encountered environmental allergens.
Keywords: Asthma; CSL311; GM-CSF; IL-3; IL-5; airway; antibody; biologic; collagen; common β cytokine; eosinophils; fibrosis; hyperactivity; inflammation; macrophages; neutrophils; remodeling; trabikibart.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.MAbs. 2016;8(3):436-53. doi: 10.1080/19420862.2015.1119352. Epub 2015 Dec 14. MAbs. 2016. PMID: 26651396 Free PMC article.
-
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure.Respirology. 2022 Aug;27(8):617-629. doi: 10.1111/resp.14297. Epub 2022 May 22. Respirology. 2022. PMID: 35599245 Free PMC article.
-
Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models.Cell Death Dis. 2022 Feb 10;13(2):137. doi: 10.1038/s41419-022-04589-z. Cell Death Dis. 2022. PMID: 35145069 Free PMC article.
-
IL-5 and IL-5 receptor in asthma.Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91. doi: 10.1590/s0074-02761997000800012. Mem Inst Oswaldo Cruz. 1997. PMID: 9698919 Review.
-
Advances in Non-Type 2 Asthma in the Severe Cases: from molecular insights to novel treatment strategies.Eur Respir J. 2024 May 2:2300826. doi: 10.1183/13993003.00826-2023. Online ahead of print. Eur Respir J. 2024. PMID: 38697650 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases